CHI3L1 and Alzheimer disease: In the present study, we demonstrate that targeting CHI3L1 with the monoclonal antibody (H1) alleviates key pathological features of Alzheimer’s disease, including neuroinflammation, amyloid accumulation, and cognitive impairment, in the Tg2576 mouse model.